Search
for
Sort by
Research 781–810 of 1000+
- Gut microbiota variation in admixed Hispanic populations with polyendocrine metabolic ovarian syndrome
- Impact of subclinical hypothyroidism on endocrine features in patients with polycystic ovary syndrome
- Cutaneous manifestations of endocrine diseases in children
- THE IMPACT OF LIFESTYLE: THE EFFECTS OF DIET, EXERCISE AND INOSITOL SUPPLEMENTATION ON THE COURSE OF POLYENDOCRINE METABOLIC OVARIAN SYNDROME (PMOS): NARRATIVE REVIEW
- Evidence for Increased 5α-Reductase Activity During Early Childhood in Daughters of Women With Polycystic Ovary Syndrome
- Causal Link of Distinct Mental Disorders with Androgenetic Alopecia and Alopecia Areata: A Bidirectional Two-Sample Mendelian Randomization Study
- 8368 Functional Evaluation Of Novel CYP21A2 Variants: Expanding The Genetic Basis Of Non-classic CAH
- 9209 Functional Evaluation Of Novel CYP21A2 Variants: Expanding The Genetic Basis Of Non-classic CAH
- Neuroendocrine, Neurotransmitter, and Gut Microbiota Imbalance Contributing to Potential Psychiatric Disorder Prevalence in PCOS
- From PCOS to PMOS: The Impact of Physical Activity, Diet, and Metabolic Health on the Course of Polyendocrine Metabolic Ovarian Syndrome
- Anti-androgen therapy in polyendocrine metabolic ovary syndrome (PMOS, formerly PCOS): efficacy, safety, and phenotype-oriented clinical decision-making
- Modern Polycystic Ovary Syndrome (PCOS) Management: Intelligent Drug Delivery and Metabolic Reprogramming for Ovarian Restoration and Fertility Optimization
- Redefining Polycystic Ovary Syndrome (PCOS) as Polyendocrine Metabolic Ovarian Syndrome (PMOS): Implications for Diagnosis, Pathophysiology and Clinical Management
- Unmasking the Overlooked Symptoms of PCOS: Navigating Ovulatory Dysfunction, Menstrual Disorders, and Acne
- Endocrine effects of long-term calcineurin inhibitor use in solid organ transplant recipients
- Integrated Multi-Omics Analysis Reveals Dysregulated Lipid Metabolism as a Novel Mechanism in Androgenetic Alopecia
- Prevalence of Cutaneous Disorders in Patients with Polycystic Ovary Syndrome
- Diabetes, ovarian tumor, hyperparathyroidism, and papillary cancer: A chance association?
- 5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder
- Diagnostic imaging in congenital adrenal hyperplasia – how does it help?
- Impaired metabolic effects of metformin in men with early-onset androgenic alopecia
- Serum adiponectin level is negatively related to insulin resistance in women with polycystic ovary syndrome
- Polycystic Ovary Syndrome and Eating Disorders—A Literature Review
- Risk of Psychiatric Disorders following Polycystic Ovary Syndrome: A Nationwide Population-Based Cohort Study
- Investigating metabolic syndrome markers and body mass index changes in patients with acne vulgaris treated with isotretinoin: A prospective study
- Androgen excess disorders remain undiagnosed in one of every four premenopausal women with Type 1 diabetes
- Síndrome dos ovários policísticos: correlação dos fenótipos com as manifestações metabólicas
- Metabolic syndrome in Greek women with polycystic ovary syndrome: prevalence, characteristics and associations with body mass index. A prospective controlled study
- Novel Insights into TSC22D Family Genes in Metabolic Diseases and Cancer
- Metabolic syndrome and dermatological diseases: association and treatment